Lightnews — Scholar-powered news

Reposted by Winship Cancer Institute of Emory University

The Academy for Radiology and Biomedical Imaging Research @acadrad.bsky.social · 14d

Announcing the Academy’s 2025 Gold Medal recipient, Dr. Lewin, MD, FACR! 🏅

This prestigious award recognizes extraordinary contributions to advancing imaging and radiology research. Click the link to learn more www.acadrad.org/wp-content/u.... @emoryradiology.bsky.social @winshipcancer.emory.edu

1 1

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · 13d

We’re celebrating one year of Winship’s HDR brachytherapy program at Emory Midtown! 🎉 Since its launch, the program has expanded access to advanced, image-guided cancer care in a state-of-the-art operative suite.

Read more ➡️ brnw.ch/21wW3Jm

2

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Sep 2

🎉 Winship, through generous support from the Arthur M. Blank Family Foundation and in collaboration with Mount Sinai Health System, celebrated the launch of the new Winship Mobile Prostate Cancer Screening Program today at a community event inside Mercedes-Benz Stadium. ➡️ brnw.ch/21wVpyk

3

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Aug 22

Winship epidemiologist Michael Goodman, MD, MPH, collaborates with India’s Center for Chronic Disease Control to strengthen cancer surveillance systems and improve how cases are tracked.

Read more ➡️ brnw.ch/21wV7KI

2

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Aug 18

Winship investigators have been awarded a total of $400,000 to support eight new projects through Winship Invest$, a peer-reviewed program designed to accelerate innovative cancer research. Learn more ➡️ brnw.ch/21wUWPO

3

Reposted by Winship Cancer Institute of Emory University

OncLive @onclive.bsky.social · Aug 7

FDA Approval of Mirdametinib Reduces Treatment Barriers for Adult Patients With NF1-Associated PNs @winshipcancer.emory.edu #oncology
www.onclive.com/view/fda-app...

FDA Approval of Mirdametinib Reduces Treatment Barriers for Adult Patients With NF1-Associated PNs

Timothy Gershon, MD, PhD, discusses how the FDA approval of mirdametinib will affect the treatment paradigm for adult patients with NF1-associated PNs.

www.onclive.com

1 2

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Aug 6

One of the biggest challenges in cancer care is when patients stop responding to treatment. A new study led by Mourad Zerfaoui, PhD, reveals how loss of a molecule called AHR fuels drug resistance in BRAF-mutant melanoma and thyroid cancer. 🔗 brnw.ch/21wUGp7

2

Reposted by Winship Cancer Institute of Emory University

Chrystal Paulos @chrystalpaulos.bsky.social · Aug 1

www.v.org/grants/chrys...
Honored to be awarded the All-Star V Foundation grant! Inspired by great team efforts between #Paulos and #Lesinski labs! Props to cell therapy gurus @megen-w.bsky.social #AnnaCole @meganmw.bsky.social and crew @winshipcancer.emory.edu

Chrystal Paulos, PhD - V Foundation

Melanoma is a serious and often deadly type of skin cancer. Although immunotherapy has saved many lives, it still doesn’t work for every patient. Our lab is developing ways to give the immune system a...

www.v.org

1 5

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 25

That wraps up the first segment of the lymphoma session at #DDHO2025, closing with a patient-centered panel discussion featuring EHA highlights and a dynamic Q&A.

1

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 25

Day 2 of #DDHO2025 is underway, kicking off with the first lymphoma session.

1

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 24

Debate: early vs delayed transplantation in myelofibrosis

Amelia Langston, MD argues for early ☀️

Michael Hochman, MD argues for delayed ⏰

#DDHO2025

1

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 24

Are ADCs Highly Promising for the Treatment of NSCLC...or... ADCs are the Futures of NSCLC?

Winship’s Conor E. Steuer, MD argues yes! #DDHO2025

1

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 24

Winship executive director Suresh Ramalingam, MD, and Winship chief medical officer Sagar Lonial, MD, kick off this year’s #DDHO2025 🎉

1

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 24

Kicking off #DDHO25 👏

1

Reposted by Winship Cancer Institute of Emory University

OncoDaily @oncodaily.bsky.social · Jul 20

Jill Barnholtz-Sloan Has Been Appointed Chief Administrative Officer and Associate Director at Winship Cancer Institute
@winshipcancer.emory.edu

oncodaily.com/career/jill-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Jill Barnholtz-Sloan Has Been Appointed Chief Administrative Officer and Associate Director at Winship Cancer Institute - OncoDaily

Jill Barnholtz-Sloan Has Been Appointed Chief Administrative Officer and Associate Director at Winship Cancer Institute / cancer, Emory University, Jill

oncodaily.com

1 7

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 17

Winship urologist Vikram Narayan, MD, FACS, was profiled by Apple for Emory Healthcare's use of Apple technology to streamline workflows and enhance patient care. 🎥 Read more and Watch the video ➡️ brnw.ch/21wUcrF

1 3 5

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 16

Winship thoracic oncologist Fatemeh Ardeshir, MD, MSc. commented on the new FDA-approved treatment option, Datroway (datopotamab deruxtecan or Dato-DXd).

The treatment is now available for people with non-small cell lung cancer (NSCLC) who harbor a common EGFR mutation. Learn more: brnw.ch/21wUbRP

2

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 14

🎗️ July is Sarcoma Awareness Month. Sarcomas are rare cancers—making up less than 1% of adult cases—with 150+ types that require expert care.

Sarcoma expert Kenneth Cardona, MD, FACS, says their rarity makes diagnosis and treatment especially challenging. Learn more ➡️ brnw.ch/21wU8tY

1

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 9

🎉Seventy-three Winship physicians were selected by their peers as "Top Doctors" for Atlanta magazine's 2025 list of the city's best doctors.

Reposted by Winship Cancer Institute of Emory University

LesinskiLab @lesinskilab.bsky.social · Jul 3

Check out our new paper in Hepatology on how myeloid cells limit immunotherapy in preclinical cholangiocarcinoma models!
Disease site matters! @chrystalpaulos.bsky.social @megen-w.bsky.social @winshipcancer.emory.edu many others!

pubmed.ncbi.nlm.nih.gov/40590857/

Tumor site influences efficacy of MEKi and immunotherapy combinations in pre-clinical model of cholangiocarcinoma - PubMed

These findings identify myeloid cells as key mediators of both immunotherapy resistance and toxicity in CCA, highlighting the critical importance of tumor site and use of physiologically relevant pre-...

pubmed.ncbi.nlm.nih.gov

1 3 7

Reposted by Winship Cancer Institute of Emory University

The Cancer Letter @cancerletter.com · Jul 5

Neil Iyengar joins @winshipcancer.emory.edu‬ as survivorship director, co-director of Breast Oncology Program
https://cancerletter.com/in-brief/20250703_7a/

Neil Iyengar joins Winship as survivorship director, co-director of Breast Oncology Program - The Cancer Letter

Breast medical oncologist and cancer survivorship expert Neil M. Iyengar was appointed director of survivorship services at Winship Cancer Institute of Emory University. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in […]

cancerletter.com

1 3

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 2

🎊Joining Winship on July 1, breast medical oncologist and cancer survivorship expert Neil M. Iyengar, MD, has been appointed director of survivorship services at Winship Cancer Institute of Emory University.

Read more ➡️ brnw.ch/21wTPea

1

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jul 1

Winship medical oncologist Kevin Kalinsky, MD, MS, FASCO, discusses how findings from the phase 3 SERENA-6 trial reinforce the importance of timely ESR1 testing in HR-positive breast cancer.

Read more ➡️ brnw.ch/21wTOyy

1

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jun 30

“Can I take this supplement?” It’s a common question after a cancer diagnosis—but it’s just one part of a bigger picture. At Winship, Naturopathic Doctor serving as an Integrative Oncology Specialist Anna Bausum, ND, FABNO, helps patients build a strong foundation to support healing. brnw.ch/21wTN9a

1

Winship Cancer Institute of Emory University @winshipcancer.emory.edu · Jun 26

🔬 Can AI paint a fuller picture of cancer?

Winship researchers, including Anant Madabhushi, PhD, and Nabil F. Saba, MD, FACP, are using AI to combine CT scans, tissue slides and epigenetic data to better predict cancer outcomes—especially for head and neck cancers. ➡️ brnw.ch/21wTHzS

Emory experts discover new insights into head and neck cancers | Emory University | Atlanta GA

Experts at Emory are utilizing artificial intelligence to break down the boundaries between different types of imaging, combining them to yield deeper insights into cancer risk and prognosis, showing ...

brnw.ch

2